GC Genome Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of A340450?
Owner Type	Number of Shares	Ownership Percentage
VC/PE Firms	2,844,444	12%
Individual Insiders	3,670,900	15.5%
Public Companies	6,932,655	29.3%
General Public	10,202,794	43.1%

Dilution of Shares: A340450 only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 56.51% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
29.2%	Green Cross Holdings Corporation	6,893,156	₩49.5b	0%	no data
12%	Ginnovation 1st Private Equity Investment Partnership	2,844,444	₩20.4b	0%	no data
3.58%	Yongjoon Heo	846,428	₩6.1b	0%	no data
3.32%	Eun-Cheol Hur	784,357	₩5.6b	0%	no data
2.15%	Il-seop Heo	507,857	₩3.6b	0%	no data
1.19%	Jinseong Heo	282,142	₩2.0b	0%	no data
0.72%	Chang-Seok Ki	169,285	₩1.2b	0%	no data
0.64%	Songhyun Yang	152,357	₩1.1b	0%	no data
0.58%	Eun-Hae Cho	138,250	₩992.6m	0%	no data
0.48%	Jinhoon Heo	112,857	₩810.3m	0%	no data
0.43%	Yong-Tae Park	101,571	₩729.3m	0%	no data
0.24%	Dae-Woo Park	57,714	₩414.4m	0%	no data
0.24%	Sun-Young Park	56,428	₩405.2m	0%	no data
0.21%	Chang-Seop Kim	50,785	₩364.6m	0%	no data
0.21%	Pyeong-Ju Jang	50,785	₩364.6m	0%	no data
0.21%	Seunghee Choi	50,785	₩364.6m	0%	no data
0.18%	Eun-hui Lee	41,571	₩298.5m	0%	no data
0.16%	Sang-Gon Lee	38,089	₩273.5m	0%	no data
0.14%	Sangman Kim	33,857	₩243.1m	0%	no data
0.13%	Woobong Kang	30,089	₩216.0m	0%	no data
0.12%	Youngju Bang	28,857	₩207.2m	0%	no data
0.11%	Du-Hong Park	25,392	₩182.3m	0%	no data
0.095%	Deukjoo Lee	22,571	₩162.1m	0%	no data
0.095%	GC Cell Corporation	22,571	₩162.1m	0%	no data
0.095%	Yeon-Geun Kim	22,571	₩162.1m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/05 10:15
End of Day Share Price	2025/11/05 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GC Genome Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.